Nasopharyngeal activation of STING pathway protects from SARs-CoV-2 and influenza in animal models HOUSTON, July 30, 2024 /PRNewswire/ — AuraVax Therapeutics, Inc, recognized its academic collaborators at the University of Houston on publication of their pre-clinical research…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.